US Stock MarketDetailed Quotes

RCUS Arcus Biosciences

Watchlist
  • 15.410
  • +0.020+0.13%
Close Sep 27 16:00 ET
  • 15.410
  • 0.0000.00%
Post 16:09 ET
1.41BMarket Cap-4954P/E (TTM)

Arcus Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
34.48%39M
480.00%145M
4.46%117M
-8.82%31M
-3.03%32M
7.41%29M
38.89%25M
-70.76%112M
-90.41%34M
248.80%33M
Operating revenue
34.48%39M
480.00%145M
4.46%117M
-8.82%31M
-3.03%32M
7.41%29M
38.89%25M
-70.76%112M
-90.41%34M
248.80%33M
Cost of revenue
Gross profit
Operating expense
29.46%145M
27.03%141M
16.58%457M
12.96%122M
8.74%112M
16.67%112M
30.59%111M
19.15%392M
46.74%108M
17.58%103M
Selling and administrative expenses
7.14%30M
6.67%32M
12.50%117M
3.57%29M
15.38%30M
7.69%28M
25.00%30M
44.44%104M
21.69%28M
59.09%26M
-General and administrative expense
7.14%30M
6.67%32M
12.50%117M
3.57%29M
15.38%30M
7.69%28M
25.00%30M
44.44%104M
21.69%28M
59.09%26M
Research and development costs
36.90%115M
34.57%109M
18.06%340M
16.25%93M
6.49%82M
20.00%84M
32.79%81M
12.06%288M
58.14%80M
8.06%77M
Operating profit
-27.71%-106M
104.65%4M
-21.43%-340M
-22.97%-91M
-14.29%-80M
-20.29%-83M
-28.36%-86M
-618.52%-280M
-126.33%-74M
10.41%-70M
Net non-operating interest income expense
44.44%13M
50.00%12M
178.57%39M
57.14%11M
120.00%11M
350.00%9M
8M
1,300.00%14M
1,248.75%7M
3,005.59%5M
Non-operating interest income
44.44%13M
44.44%13M
156.25%41M
37.50%11M
140.00%12M
200.00%9M
--9M
1,500.00%16M
1,441.43%8M
3,005.59%5M
Non-operating interest expense
--0
0.00%1M
0.00%2M
--0
--1M
--0
--1M
--2M
--1M
--0
Other net income (expense)
-20M
Special income (charges)
--0
---20M
----
----
----
--0
--0
----
----
----
-Less:Impairment of capital assets
--0
--20M
----
----
----
--0
--0
----
----
----
Income before tax
-25.68%-93M
94.87%-4M
-13.16%-301M
-19.40%-80M
-6.15%-69M
-10.45%-74M
-16.42%-78M
-583.64%-266M
-123.80%-67M
16.64%-65M
Income tax
0
0
500.00%6M
1M
2M
1M
100.00%2M
-50.00%1M
0
0
Net income
-24.00%-93M
95.00%-4M
-14.98%-307M
-20.90%-81M
-9.23%-71M
-11.94%-75M
-17.65%-80M
-603.77%-267M
-123.97%-67M
16.64%-65M
Net income continuous Operations
-24.00%-93M
95.00%-4M
-14.98%-307M
-20.90%-81M
-9.23%-71M
-11.94%-75M
-17.65%-80M
-603.77%-267M
-123.97%-67M
16.64%-65M
Minority interest income
Net income attributable to the parent company
-24.00%-93M
95.00%-4M
-14.98%-307M
-20.90%-81M
-9.23%-71M
-11.94%-75M
-17.65%-80M
-603.77%-267M
-123.97%-67M
16.64%-65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-24.00%-93M
95.00%-4M
-14.98%-307M
-20.90%-81M
-9.23%-71M
-11.94%-75M
-17.65%-80M
-603.77%-267M
-123.97%-67M
16.64%-65M
Basic earnings per share
1.92%-1.02
95.41%-0.05
-11.86%-4.15
-16.13%-1.08
-4.44%-0.94
-11.83%-1.04
-13.54%-1.09
-588.16%-3.71
-123.43%-0.93
18.92%-0.9
Diluted earnings per share
1.92%-1.02
95.41%-0.05
-11.86%-4.15
-16.13%-1.08
-4.44%-0.94
-11.83%-1.04
-13.54%-1.09
-622.54%-3.71
-125.07%-0.93
18.92%-0.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 34.48%39M480.00%145M4.46%117M-8.82%31M-3.03%32M7.41%29M38.89%25M-70.76%112M-90.41%34M248.80%33M
Operating revenue 34.48%39M480.00%145M4.46%117M-8.82%31M-3.03%32M7.41%29M38.89%25M-70.76%112M-90.41%34M248.80%33M
Cost of revenue
Gross profit
Operating expense 29.46%145M27.03%141M16.58%457M12.96%122M8.74%112M16.67%112M30.59%111M19.15%392M46.74%108M17.58%103M
Selling and administrative expenses 7.14%30M6.67%32M12.50%117M3.57%29M15.38%30M7.69%28M25.00%30M44.44%104M21.69%28M59.09%26M
-General and administrative expense 7.14%30M6.67%32M12.50%117M3.57%29M15.38%30M7.69%28M25.00%30M44.44%104M21.69%28M59.09%26M
Research and development costs 36.90%115M34.57%109M18.06%340M16.25%93M6.49%82M20.00%84M32.79%81M12.06%288M58.14%80M8.06%77M
Operating profit -27.71%-106M104.65%4M-21.43%-340M-22.97%-91M-14.29%-80M-20.29%-83M-28.36%-86M-618.52%-280M-126.33%-74M10.41%-70M
Net non-operating interest income expense 44.44%13M50.00%12M178.57%39M57.14%11M120.00%11M350.00%9M8M1,300.00%14M1,248.75%7M3,005.59%5M
Non-operating interest income 44.44%13M44.44%13M156.25%41M37.50%11M140.00%12M200.00%9M--9M1,500.00%16M1,441.43%8M3,005.59%5M
Non-operating interest expense --00.00%1M0.00%2M--0--1M--0--1M--2M--1M--0
Other net income (expense) -20M
Special income (charges) --0---20M--------------0--0------------
-Less:Impairment of capital assets --0--20M--------------0--0------------
Income before tax -25.68%-93M94.87%-4M-13.16%-301M-19.40%-80M-6.15%-69M-10.45%-74M-16.42%-78M-583.64%-266M-123.80%-67M16.64%-65M
Income tax 00500.00%6M1M2M1M100.00%2M-50.00%1M00
Net income -24.00%-93M95.00%-4M-14.98%-307M-20.90%-81M-9.23%-71M-11.94%-75M-17.65%-80M-603.77%-267M-123.97%-67M16.64%-65M
Net income continuous Operations -24.00%-93M95.00%-4M-14.98%-307M-20.90%-81M-9.23%-71M-11.94%-75M-17.65%-80M-603.77%-267M-123.97%-67M16.64%-65M
Minority interest income
Net income attributable to the parent company -24.00%-93M95.00%-4M-14.98%-307M-20.90%-81M-9.23%-71M-11.94%-75M-17.65%-80M-603.77%-267M-123.97%-67M16.64%-65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -24.00%-93M95.00%-4M-14.98%-307M-20.90%-81M-9.23%-71M-11.94%-75M-17.65%-80M-603.77%-267M-123.97%-67M16.64%-65M
Basic earnings per share 1.92%-1.0295.41%-0.05-11.86%-4.15-16.13%-1.08-4.44%-0.94-11.83%-1.04-13.54%-1.09-588.16%-3.71-123.43%-0.9318.92%-0.9
Diluted earnings per share 1.92%-1.0295.41%-0.05-11.86%-4.15-16.13%-1.08-4.44%-0.94-11.83%-1.04-13.54%-1.09-622.54%-3.71-125.07%-0.9318.92%-0.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data